{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:34:39Z","timestamp":1759775679329,"version":"3.41.2"},"reference-count":47,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172823, 81372448"],"award-info":[{"award-number":["81172823, 81372448"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004610","name":"Science and Technology Support Program of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2012739"],"award-info":[{"award-number":["BE2012739"]}],"id":[{"id":"10.13039\/501100004610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00657","type":"journal-article","created":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T03:46:02Z","timestamp":1496979962000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["An Antigen-Presenting and Apoptosis-Inducing Polymer Microparticle Prolongs Alloskin Graft Survival by Selectively and Markedly Depleting Alloreactive CD8+ T Cells"],"prefix":"10.3389","volume":"8","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khawar Ali","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaochen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanlai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2147\/dddt.s41349","article-title":"Tacrolimus in preventing transplant rejection in Chinese patients \u2013 optimizing use","volume":"9","author":"Li","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"Cd010699","DOI":"10.1002\/14651858.CD010699.pub2","article-title":"Belatacept for kidney transplant recipients","volume":"11","author":"Masson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"9156","DOI":"10.3748\/wjg.v19.i48.9156","article-title":"Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients","volume":"19","author":"Provenzani","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/1521-4141(200206)32:6<1679::AID-IMMU1679>3.0.CO;2-5","article-title":"B cells engineered to express Fas ligand suppress pre-sensitized antigen-specific T cell responses in vivo","volume":"32","author":"Kosiewicz","year":"2002","journal-title":"Eur J Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2567.2011.03417.x","article-title":"Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells","volume":"133","author":"Schutz","year":"2011","journal-title":"Immunology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.4049\/jimmunol.177.4.2691","article-title":"Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells","volume":"177","author":"Hoves","year":"2006","journal-title":"J Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/11375","article-title":"Induction of antigen-specific immunosuppression by CD95L cDNA-transfected \u2018killer\u2019 dendritic cells","volume":"5","author":"Matsue","year":"1999","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1182\/blood.V98.12.3465","article-title":"Immunosuppressive properties of CD95L-transduced \u201ckiller\u201d hybrids created by fusing donor- and recipient-derived dendritic cells","volume":"98","author":"Matsue","year":"2001","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1074-7613(02)00482-X","article-title":"Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection","volume":"17","author":"Yolcu","year":"2002","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1182\/blood-2002-01-0118","article-title":"Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation","volume":"100","author":"Whartenby","year":"2002","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/1521-4141(200204)32:4<1035::AID-IMMU1035>3.0.CO;2-7","article-title":"Killing of naive T cells by CD95L-transfected dendritic cells (DC): in vivo study using killer DC-DC hybrids and CD4(+) T cells from DO11.10 mice","volume":"32","author":"Kusuhara","year":"2002","journal-title":"Eur J Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.4049\/jimmunol.170.11.5406","article-title":"Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC","volume":"170","author":"Hoves","year":"2003","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-2249.2004.02514.x","article-title":"Dendritic cells overexpressing Fas-ligand induce pulmonary vasculitis in mice","volume":"137","author":"Buonocore","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/sj.cdd.4402019","article-title":"Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity","volume":"14","author":"Strauss","year":"2007","journal-title":"Cell Death Differ"},{"key":"B15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jneuroim.2012.06.007","article-title":"Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo: the guided missile strategy","volume":"251","author":"Sun","year":"2012","journal-title":"J Neuroimmunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00109-006-0047-3","article-title":"Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma","volume":"84","author":"Chuang","year":"2006","journal-title":"J Mol Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4049\/jimmunol.164.1.161","article-title":"Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival","volume":"164","author":"Min","year":"2000","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2217\/imt.10.26","article-title":"Killer artificial antigen-presenting cells: the synthetic embodiment of a \u2018guided missile\u2019","volume":"2","author":"Schutz","year":"2010","journal-title":"Immunotherapy"},{"key":"B19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Greenwald","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1182\/blood-2002-07-2042","article-title":"Dendritic cells overexpressing CD95 (Fas) ligand elicit vigorous allospecific T-cell responses in vivo","volume":"101","author":"Buonocore","year":"2003","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.4049\/jimmunol.164.6.3095","article-title":"CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity","volume":"164","author":"Hermans","year":"2000","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1182\/blood-2004-01-0324","article-title":"Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers","volume":"104","author":"Yuan","year":"2004","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.4049\/jimmunol.167.7.3708","article-title":"Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers","volume":"167","author":"Maile","year":"2001","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1182\/blood-2006-06-028001","article-title":"Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin","volume":"109","author":"Hess","year":"2007","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1182\/blood-2007-09-113522","article-title":"Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells","volume":"111","author":"Schutz","year":"2008","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.imlet.2011.04.002","article-title":"Killer artificial antigen-presenting cells deplete alloantigen-specific T cells in a murine model of alloskin transplantation","volume":"138","author":"Shen","year":"2011","journal-title":"Immunol Lett"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1007\/s11095-014-1419-y","article-title":"Biomaterials for nanoparticle vaccine delivery systems","volume":"31","author":"Sahdev","year":"2014","journal-title":"Pharm Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"415289","DOI":"10.1155\/2015\/415289","article-title":"Bone regeneration from PLGA micro-nanoparticles","volume":"2015","author":"Ortega-Oller","year":"2015","journal-title":"Biomed Res Int"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6585","DOI":"10.1016\/j.biomaterials.2014.04.042","article-title":"Repair of spinal cord injury by inhibition of astrocyte growth and inflammatory factor synthesis through local delivery of flavopiridol in PLGA nanoparticles","volume":"35","author":"Ren","year":"2014","journal-title":"Biomaterials"},{"key":"B30","doi-asserted-by":"publisher","first-page":"12176","DOI":"10.18632\/oncotarget.7519","article-title":"A biodegradable killer microparticle to selectively deplete antigen-specific T cells in vitro and in vivo","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"B31","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3791\/634","article-title":"Murine skin transplantation","volume":"11","author":"Garrod","year":"2008","journal-title":"J Vis Exp"},{"key":"B32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cca.2013.02.016","article-title":"CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity","volume":"421","author":"Brandhorst","year":"2013","journal-title":"Clin Chim Acta"},{"key":"B33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1146\/annurev-bioeng-071813-104814","article-title":"Biomaterial strategies for immunomodulation","volume":"17","author":"Hotaling","year":"2015","journal-title":"Annu Rev Biomed Eng"},{"key":"B34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.clim.2015.04.013","article-title":"Micro and nanoparticle drug delivery systems for preventing allotransplant rejection","volume":"160","author":"Fisher","year":"2015","journal-title":"Clin Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nature08604","article-title":"Materials engineering for immunomodulation","volume":"462","author":"Hubbell","year":"2009","journal-title":"Nature"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nbt.2434","article-title":"Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis","volume":"30","author":"Getts","year":"2012","journal-title":"Nat Biotechnol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"8887","DOI":"10.1016\/j.biomaterials.2014.06.044","article-title":"Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation","volume":"35","author":"Bryant","year":"2014","journal-title":"Biomaterials"},{"key":"B38","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.1073\/pnas.1408686111","article-title":"Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance","volume":"112","author":"Maldonado","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"11270","DOI":"10.1073\/pnas.1120611109","article-title":"Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis","volume":"109","author":"Yeste","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B40","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.immuni.2010.03.015","article-title":"Reversal of autoimmunity by boosting memory-like autoregulatory T cells","volume":"32","author":"Tsai","year":"2010","journal-title":"Immunity"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1002\/adma.201200224","article-title":"Biomimetic delivery with micro- and nanoparticles","volume":"24","author":"Balmert","year":"2012","journal-title":"Adv Mater Deerfield"},{"key":"B42","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/jps.24273","article-title":"Multivalent nanomaterials: learning from vaccines and progressing to antigen-specific immunotherapies","volume":"104","author":"Hartwell","year":"2015","journal-title":"J Pharm Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/bit.21301","article-title":"Microparticles and nanoparticles for drug delivery","volume":"96","author":"Kohane","year":"2007","journal-title":"Biotechnol Bioeng"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s11095-008-9562-y","article-title":"Role of particle size in phagocytosis of polymeric microspheres","volume":"25","author":"Champion","year":"2008","journal-title":"Pharm Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0171-2985(83)80071-0","article-title":"Immunogenicity of the mutated H-2Kbm1 antigen(s). Test of thyroid graft rejection between B6.C-H-2bm1 and C57BL\/6 mice following reciprocal immunization with normal versus malignant cells","volume":"165","author":"Isakov","year":"1983","journal-title":"Immunobiology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.4049\/jimmunol.0901550","article-title":"CD47 is required for suppression of allograft rejection by donor-specific transfusion","volume":"184","author":"Wang","year":"2010","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/08820139.2015.1014098","article-title":"Antigen-specific killer polylactic-co-glycolic acid (PLGA) microspheres can prolong alloskin graft survival in a murine model","volume":"44","author":"Wang","year":"2015","journal-title":"Immunol Invest"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00657\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,9]],"date-time":"2017-06-09T03:46:06Z","timestamp":1496979966000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00657\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,9]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2017.00657"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00657","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2017,6,9]]},"article-number":"657"}}